Bar Harbor Wealth Management’s GSK GSK Stock Holding History

Bar Harbor Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.52M	Buy	67,212 +120	+0.2%	+$6.35K	0.19%	104
2026 Q1	$3.7M	Hold	67,092	–	–	0.22%	98
2025 Q4	$3.29M	Hold	67,092	–	–	0.19%	105
2025 Q3	$2.9M	Hold	67,092	–	–	0.17%	109
2025 Q2	$2.58M	Hold	67,092	–	–	0.16%	114
2025 Q1	$2.6M	Hold	67,092	–	–	0.17%	113
2024 Q4	$2.27M	Hold	67,092	–	–	0.15%	115
2024 Q3	$2.74M	Hold	67,092	–	–	0.17%	117
2024 Q2	$2.58M	Hold	67,092	–	–	0.17%	114
2024 Q1	$2.88M	Hold	67,092	–	–	0.19%	113
2023 Q4	$2.49M	Hold	67,092	–	–	0.19%	111
2023 Q3	$2.43M	Hold	67,092	–	–	0.19%	107
2023 Q2	$2.39M	Hold	67,092	–	–	0.18%	111
2023 Q1	$2.39M	Hold	67,092	–	–	0.19%	107
2022 Q4	$2.36M	Buy	+67,092	New	+$2.23M	0.19%	108
2022 Q3	–	Sell	-67,093	Closed	-$3.65M	–	256
2022 Q2	$3.65M	Buy	67,093 +1,239	+2%	+$68.4K	0.29%	87
2022 Q1	$3.59M	Hold	65,854	–	–	0.32%	67
2021 Q4	$3.63M	Sell	65,854 -480	-0.7%	-$25K	0.31%	70
2021 Q3	$3.17M	Hold	66,334	–	–	0.3%	67
2021 Q2	$3.3M	Sell	66,334 -120	-0.2%	-$5.77K	0.31%	66
2021 Q1	$2.96M	Sell	66,454 -360	-0.5%	-$16.3K	0.29%	70
2020 Q4	$3.07M	Sell	66,814 -708	-1%	-$32.5K	0.31%	71
2020 Q3	$3.18M	Hold	67,522	–	–	0.35%	67
2020 Q2	$3.44M	Hold	67,522	–	–	0.4%	64
2020 Q1	$3.2M	Sell	67,522 -332	-0.5%	-$17.7K	0.43%	62
2019 Q4	$3.99M	Hold	67,854	–	–	0.44%	65
2019 Q3	$3.62M	Sell	67,854 -517	-0.8%	-$26.6K	0.42%	62
2019 Q2	$3.42M	Sell	68,371 -182	-0.3%	-$9.13K	0.4%	66
2019 Q1	$3.58M	Sell	68,553 -75	-0.1%	-$3.75K	0.43%	59
2018 Q4	$3.28M	Hold	68,628	–	–	0.44%	56
2018 Q3	$3.45M	Hold	68,628	–	–	0.39%	61
2018 Q2	$3.46M	Buy	68,628 +119	+0.2%	+$5.99K	0.42%	59
2018 Q1	$3.35M	Sell	68,509 -1,179	-2%	-$54.9K	0.41%	59
2017 Q4	$3.09M	Sell	69,688 -407	-0.6%	-$18.8K	0.36%	63
2017 Q3	$3.56M	Hold	70,095	–	–	0.43%	51
2017 Q2	$3.78M	Sell	70,095 -2,687	-4%	-$143K	0.45%	50
2017 Q1	$3.83M	Sell	72,782 -6,886	-9%	-$349K	0.45%	47
2016 Q4	$3.83M	Hold	79,668	–	–	0.42%	50
2016 Q3	$4.29M	Sell	79,668 -630	-0.8%	-$34.5K	0.49%	47
2016 Q2	$4.35M	Sell	80,298 -71	-0.1%	-$3.74K	0.51%	47
2016 Q1	$4.07M	Hold	80,369	–	–	0.5%	49
2015 Q4	$4.05M	Hold	80,369	–	–	0.51%	48
2015 Q3	$3.86M	Sell	80,369 -439	-0.5%	-$22.9K	0.51%	50
2015 Q2	$4.21M	Sell	80,808 -63	-0.1%	-$3.55K	0.51%	52
2015 Q1	$4.67M	Sell	80,871 -455	-0.6%	-$26.1K	0.57%	49
2014 Q4	$4.34M	Sell	81,326 -72	-0.1%	-$4.03K	0.54%	52
2014 Q3	$4.68M	Hold	81,398	–	–	0.6%	48
2014 Q2	$5.44M	Buy	81,398 +496	+0.6%	+$33.6K	0.68%	44
2014 Q1	$5.4M	Hold	80,902	–	–	0.69%	43
2013 Q4	$5.4M	Sell	80,902 -983	-1%	-$63.7K	0.7%	41
2013 Q3	$5.13M	Buy	81,885 +122	+0.1%	+$7.85K	0.72%	40
2013 Q2	$5.11M	Buy	+81,763	New	+$5.19M	0.74%	39

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bar Harbor Wealth Management's GSK Position: Q2 2026 in Review

Bar Harbor Wealth Management increased its GSK (GSK) stake by 0.18% in Q2 2026, buying an estimated $6.35K and bringing the position to 67,212 shares worth $3.52M. The position accounts for 0.19% of the portfolio, ranked #104.

Bar Harbor Wealth Management first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.44M in Q2 2014. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Bar Harbor Wealth Management held 67,212 shares of GSK worth $3.52M as of Q2 2026.
Bar Harbor Wealth Management bought 120 GSK shares in Q2 2026, an estimated $6.35K.
GSK made up 0.19% of Bar Harbor Wealth Management's portfolio in Q2 2026, its #104 holding.
Bar Harbor Wealth Management first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
Bar Harbor Wealth Management's GSK position peaked at $5.44M in Q2 2014.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Bar Harbor Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.